Telix Pharmaceuticals Director Marie McDonald Acquires 7,812 Shares and 1,095 NED Rights in Late October 2026

Anjali Anand

03 November 2026 08:45 PM AEDT

Telix Pharmaceuticals Director Marie McDonald Acquires 7,812 Shares and 1,095 NED Rights in Late October 2026

Image Source: Krish Capital Pty Ltd

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Telix Pharmaceuticals Limited (ASX:TLX) has disclosed a change in the relevant interests of director Marie McDonald, following an on-market share purchase on 27 October 2026 and an allocation of NED Share Rights on 29 October 2026, according to a Change of Director's Interest Notice lodged with the exchange.

Key Points

Marie McDonald acquired 7,812 fully paid ordinary shares on-market on 27 October 2026 at $12.8084 per share.
McDonald received an allocation of 1,095 NED Share Rights on 29 October 2026 at $16.4352 per share, calculated based on the 20-day VWAP from 21 August 2026.
The NED Share Rights were allocated under the Telix Non-Executive Director Rights plan using the director's salary sacrificed contribution.
The transactions were not conducted during a closed period requiring prior written clearance.

On-Market Share Purchase by Director McDonald

According to the filing, Marie McDonald acquired 7,812 fully paid ordinary shares through an on-market purchase on 27 October 2026 at a price of $12.8084 per share. The shares are held by Netwealth Investments Limited as custodian for Cosmo Cap Pty Ltd, which is beneficially owned and controlled by Marie McDonald. Prior to this transaction, Netwealth Investments Limited as custodian held 3,719 fully paid ordinary shares on behalf of McDonald. Following the purchase, the filing records 7,812 fully paid ordinary shares held by Netwealth Investments Limited as custodian for Cosmo Capital, in addition to the existing 3,719 shares held under the McDonald custodian arrangement.

NED Share Rights Allocation Under Telix Rights Plan

On 29 October 2026, McDonald received an allocation of 1,095 NED Share Rights in her own name under the Telix Non-Executive Director Rights plan. The allocation price was $16.4352 per share, calculated based on the 20-day volume-weighted average price from 21 August 2026, as set out in the Telix NED Rights plan terms. The filing states the rights were allocated using the director's salary sacrificed contribution. Prior to this allocation, McDonald held 23,139 Stock Appreciation Rights in her name. Following both transactions, McDonald holds 23,139 Stock Appreciation Rights and 1,095 NED Share Rights in her name.

Director's Interest Holdings Following Transactions

After the disclosed changes, the filing records Marie McDonald's aggregate securities position as: 3,719 fully paid ordinary shares held by Netwealth Investments Limited as custodian for Marie Elizabeth McDonald; 7,812 fully paid ordinary shares held by Netwealth Investments Limited as custodian for Cosmo Capital; 23,139 Stock Appreciation Rights in the name of Marie McDonald; and 1,095 NED Share Rights in the name of Marie McDonald. No securities were disposed of in connection with either transaction. No changes to director's interests in contracts were disclosed in the filing.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.